Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
1.140
-0.080 (-6.56%)
Oct 30, 2025, 10:00 AM EDT - Market open
Applied Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
$4.13
Upside
+262.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $1.5 | Hold | Reiterates | $1.5 | +31.58% | May 14, 2025 |
| William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 23, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $4 → $1.5 | Hold | Maintains | $4 → $1.5 | +31.58% | Dec 20, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades $13 → $2 | Strong Buy → Hold | Downgrades | $13 → $2 | +75.44% | Dec 2, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $13 → $8 | Strong Buy | Maintains | $13 → $8 | +601.75% | Nov 29, 2024 |
| Baird | Baird | Buy Maintains $14 → $5 | Buy | Maintains | $14 → $5 | +338.60% | Nov 29, 2024 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +250.88% | Nov 29, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $13 | Strong Buy | Maintains | $11 → $13 | +1,040.35% | Nov 27, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +864.91% | Sep 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +1,128.07% | Sep 19, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +601.75% | Aug 27, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 31, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +952.63% | Jul 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +952.63% | Apr 11, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $12 | Buy | Initiates | $12 | +952.63% | Mar 26, 2024 |
| UBS | UBS | Strong Buy Maintains $12 → $13 | Strong Buy | Maintains | $12 → $13 | +1,040.35% | Mar 15, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.